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Abstract  
Women with the FMR1 premutation appear to be at increased risk for executive 
dysfunction.  Findings in this regard have been mixed, leading to controversy 
surrounding the executive phenotype.  Inhibitory deficits have been a more consistently 
documented component of this cognitive profile (Klusek et al., 2020; Shelton et al., 
2014).  This study aimed to clarify the executive phenotype through use of the 
antisaccade task, a well referenced eye-tracking paradigm that targets oculomotor 
inhibition and motor control and imposes time constraints that may increase sensitivity to 
executive deficits in women with the FMR1 premutation.  The effects of aging were 
examined in both groups on performance in this paradigm, as emerging research has 
referenced cognitive decline with age in the FMR1 premutation.  Participants included 35 
women with the FMR1 premutation and 27 control women.  Decreased abilities in both 
the motor and inhibitory command portion of this task were exhibited by women with the 
FMR1 premutation.  Longer latency was also associated with older age in the FMR1 
premutation group, suggesting premature aging in this population.  These findings may 
elucidate the underpinnings of this phenotype, inform age-related decline in this 
population, and provide information to successfully target these deficits in order to 
improve quality of life
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Chapter 1 
Introduction 
There are estimated to be one million women in the United States who carry a 
genetic mutation known as the FMR1 premutation (Maenner et al., 2013).  The FMR1 
premutation is defined as an expansion of 55-200 CGG repeats on the FMR1 gene found 
on the X chromosome.  Women with the FMR1 premutation are sometimes referred to as 
“fragile X carriers'' because premutation repeat lengths are unstable upon 
intragenerational transmission, and may be translated into the full mutation when passed 
down from mother to child (Willemsen et al., 2011; Yu et al, 1991; Oberle et al., 1991; 
Nolin et al., 2003).  The full mutation, which causes fragile X syndrome, is the result of 
an expansion of >200 CGG repeats on the FMR1 gene.  This population of individuals 
continues to be described in the literature, as fragile X syndrome is associated with 
serious neurodevelopmental consequences such as intellectual disability and autism 
spectrum disorder.  The FMR1 premutation also represents a clinical population of 
interest as recent evidence suggests that individuals with the FMR1 premutation are at 
risk for a range of symptoms and disorders associated with their genetic status.  However, 
the phenotype of the FMR1 premutation continues to remain largely undefined in 
research, particularly in women who are believed to show a more subtle symptom profile 
due to the protective effects of the second X chromosome.  There is a need for additional 
research aimed at defining the FMR1 premutation phenotype, considering that the 
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premutation expansion affects 1 in 151 females and 1 in 486 males in the United States 
(Seltzer et al., 2012).  Both males and females with the FMR1 premutation may 
experience neurodevelopmental and neurodegenerative differences not seen in the 
general population (Shelton et al., 2014; Jacquemont et al., 2007).  Some common 
medical and psychiatric challenges observed are immune mediated disorders, migraines 
and/or headaches, vestibular issues and mood disorders including depression and anxiety 
(Winarni et al., 2012; Au et al., 2013; Smith et al., 2012; Seltzer et al., 2012; Johnston et 
al., 2001; Lachiewicz et al., 2006; Seltzer et al., 2012).  Two specific conditions, 
however, are solely associated with the FMR1 premutation.  This includes risk for 
developing a late-onset neurodegenerative condition known as fragile X tremor/ataxia 
syndrome (FXTAS), which typically first manifests over the age of 50 (Rodriguez-
Revenga et al., 2009).  Women with the premutation may also develop fragile X primary 
ovarian insufficiency (FXPOI), characterized by premature menopause, in about 20% of 
premutation carriers as compared to 1% of the general population (Shelton et al., 2014; 
Rodriguez-Revenga et al., 2009; Sherman, 2000).  As both FXTAS and FXPOI are age-
related disorders, researchers have begun to conceptualize the FMR1 premutation as a 
condition of premature biological aging.  This aligns with emerging evidence that other 
aspects of the FMR1 premutation phenotype, such as executive dysfunction, also show 
age-related decline.  For example, verbal inhibition deficits in women with the FMR1 
premutation are correlated with older age (Klusek et al., 2020).  
Although cognitive deficits, particularly executive dysfunction, have been 
documented in prior research, the executive profile remains an area of controversy in 
women with the FMR1 premutation (Loesch et al., 2003; Grigsby et al, 2008; Cornish et 
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al., 2008; Lachiewicz et al., 2006).  Some studies have found evidence of executive 
deficits in the domains including verbal fluency, response inhibition, mental flexibility, 
and working memory (Shelton et al., 2014; Kogan et al., 2010).  However, not all studies 
have found evidence of executive deficits (e.g., Hunter et al., 2008).  Age of the sample is 
thought to be one source of inconsistency, given evidence that premutation symptoms 
may become more pronounced with age.  Measurement effects may represent another 
source of inconsistency.  For example, many studies employing self-report and broad 
neuropsychological test batteries have failed to detect executive differences between 
women with the FMR1 premutation and controls (Hunter et al., 2008).  In contrast, tasks 
that impose time constraints in the measurement of executive dysfunction have been 
more successful at differentiating women with the FMR1 premutation from controls 
(Kraan et al., 2014; Shelton et al., 2016; Klusek et al., 2020).       
In the present study, we employed the antisaccade task as a measure of response 
inhibition that may impose time constraints and therefore may have increased sensitivity 
to executive deficits in the FMR1 premutation.  In this paradigm, the participant is 
directed to look at or away from a target as it appears on a computer screen, as quickly as 
possible.  The recorded eye movements are called ‘prosaccades’ (looking at the target) or 
‘antisaccades’ (looking away from the object).  Response time in the prosaccade 
condition, where the individual looks at the target, directly indexes sensory motor control 
(Peltsch et al., 2014).  In contrast, the antisaccade trials require the participant to 
voluntarily inhibit an automatic response towards the visual stimulus by looking in the 
opposite direction, showing ability to suppress a prepotent response (Munoz & Everling, 
2004).  This condition provides an index of response suppression and voluntary motor 
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command.  Variables commonly extracted from the prosaccade and antisaccade condition 
include peak velocity and latency which reflect activation and inhibition, subdomains of 
executive functioning, as well as motor control (Mirsky et al., 2011).  Saccade latency 
can be described as the amount of time elapsed between the presentation of the stimuli 
and the initiation of a saccade (Carpenter, 1988).  Peak velocity is a measure of how 
quickly the eyes move from an area of fixation to the target stimuli, after the eye 
movement is initiated.  Finally, error rate for the antisaccade condition is measured when 
an individual directs their gaze towards the target when told to avert their gaze.  
Antisaccade error rates increase with decreased inhibition abilities (Antoniades et al., 
2013; Hallett, 1978).   
Although the antisaccade task appears relatively simple in nature, it measures 
various underlying cognitive processes that are otherwise difficult to assess.  The ability 
to extract information on both the accuracy and the latency (timing) of responses is also 
advantageous as it may facilitate the detection of subtle deficits.  Therefore, it has been 
suggested that performance on this paradigm may be useful in tracking the progression of 
neurodegenerative disease including Parkinson’s, Alzheimer’s, and spinocerebellar ataxia 
(Deubel & Schneider, 2003; Anderson & MacAskill, 2013; MacAskill & Anderson, 
2016).  For example, in individuals with Parkinson’s, saccades are often hypometric and 
show prolonged latencies.  Even early on in this disorder, increased errors are found in 
the antisaccade portion of the task (Gorges et al., 2015; Antoniades et al., 2015; 
MacAskill & Anderson, 2016).  Individuals with the FMR1 premutation are also at risk 
for neurodegenerative disease (FXTAS).  Therefore, there is potential utility in applying 
the antisaccade task to the FMR1 premutation because this measure may be more 
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sensitive to the earliest signs of neurodegeneration (Hagerman et al., 2004; Antoniades et 
al., 2015). 
Preliminary evidence supports the promise of the antisaccade task as a measure of 
inhibition in individuals with the FMR1 premutation.  One study in 21 males with the 
FMR1 premutation who were asymptomatic of FXTAS has been performed.  Findings 
supported inhibitory deficits, marked by increased latency in the antisaccade condition, 
but no noticeable differences in oculomotor control were detected as indicated by 
performance on the prosaccade condition (Wong et al., 2014).  However, this study solely 
examined males with the FMR1 premutation therefore, it remains unclear whether these 
results generalize to women with the FMR1 premutation who experience subtler 
symptoms due to the protective effects of the second X chromosome.  A preliminary 
report by Shelton et al. (2014) found increases in antisaccade errors in a small sample 
size of 14 women with the FMR1 premutation as compared to the control group.  No 
other significant differences were found between these women with the FMR1 
premutation and controls in the latency of responses.    
This study extends these preliminary findings to test oculomotor inhibition skills 
in a larger sample of women with the FMR1 premutation, and to test the presence of age 
effects.  Our research questions are: 
1. Do women with the FMR1 premutation exhibit differences in performance 
on the antisaccade task (on both prosaccades & antisaccades) compared to 
neurotypical control women?  We hypothesize that women with the FMR1 
premutation will show deficits in particular areas of this task including 
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longer latency, slower peak velocity, as well as increased errors on the 
antisaccade portion of this task. 
2. What is the effect of age on performance in the prosaccade and 
antisaccade condition of women with the FMR1 premutation and does this 
differ from controls?  We hypothesize that as women with the FMR1 
premutation age, they will exhibit increased errors as well as decreased 
latency on the antisaccade task. 
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Chapter 2 
Methods 
Participants 
Participants included 35 women with the FMR1 premutation (55-200 CGG 
repeats; experimental group) and 27 mothers of typically developing children (control 
group).  The control group comprised of mothers of typically developing children in 
order to reduce the possibility of a family history of fragile X syndrome, in turn, reducing 
the probability that the control participants carried the FMR1 premutation themselves.  
There were several additional individuals (4 women with the FMR1 premutation and 3 
control women) who were recruited for this study but didn’t participate in the eye 
tracking component due to inability to calibrate eye tracker (e.g., participant wore blue-
light blocking glasses). 
In facilitating recruitment, women with the FMR1 premutation were recruited 
through social media and word of mouth as well as through their children who were 
participating in developmental studies of fragile X syndrome with nation-wide 
recruitment.  Control women were recruited locally through social media, word of mouth, 
and flyers posted on the University of South Carolina campus as well as in local 
pediatricians’ offices.  Inclusionary criteria for the study were as follows: All participants 
were fluent speakers of English.  Presence of the FMR1 premutation was confirmed via 
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genetic testing or by medical record review.  Children of the women in the control group 
were considered typically developing as determined by no parent reported history of 
developmental delay as well as parental screening for autism symptoms through the use 
of Social Communication Questionnaire (SCQ; Rutter et al., 2014).  All control women 
scored above 80 on the Kaufman Brief Intelligence Test, 2nd edition (KBIT-2; Kaufman et 
al., 2013). 
Procedures 
The antisaccade task was integrated into a three-hour research protocol in which 
family outcomes as well as language and cognitive abilities were examined.  This 
particular task took place an hour into the protocol, after executive functioning measures 
and language sample, and took about 20 minutes.  Informed consent was obtained from 
all participants and procedures were approved by the Institutional Review Board of the 
University of South Carolina.    
Measures 
Apparatus/Instrumentation 
Eye movement was measured using the Eyelink 1000 Plus eyetracker (SR 
Research Ltd, Ontario, Canada).  Stimuli were presented on a Ben-Q 2420T monitor (530 
mm x 300 mm x 768 pixels, 60 Hz).  A chin rest, centered at a distance of 750 mm from 
the display screen, was used to facilitate correct positioning of the participant’s head 
during recording, although recordings were conducted in remote mode.  An initial nine-
point calibration and validation were performed at the start of the procedure.  
Recalibration was performed as needed.  Calibrations were accepted if the average error 
was less than <.5° and the maximum error <1.00°.      
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Stimuli/Paradigm 
Design of the antisaccade task was modeled after the standardized protocol 
described by Antoniades et al., (2013).  The paradigm consisted of ten prosaccade 
practice trials with feedback, a block of 60 prosaccade trials, five antisaccade practice 
trials with feedback, three blocks of 40 antisaccade trials each, and a final block of 60 
prosaccade trials.  Participants were offered breaks between each block, and the entire 
task lasted about 20 minutes.  Prior to the prosaccade trials, participants were provided 
the following instructions: “Look at the central X; as soon as a new dot appears on the 
left or right, look at it as fast as you can.”  The instructions preceding the antisaccade 
trials were as follows: “Look at the central X; as soon as a new dot appears on the left or 
right, look the same distance in the opposite direction, as fast as you can.”  Directions 
were presented verbally by the examiner as well as visually on the screen.  
Each block began with a drift check consisting of a 1° diameter black circle 
presented on the center of a grey screen.  The drift check was followed by a fixation 
screen with a black “X” (1° x 1.5°) presented in the center of a grey screen.  The central 
fixation “X” was surrounded by black flanking square markers (0.5° x 0.5°) presented 8° 
to the left and right, marking the potential target location.  The fixation screen was 
displayed for an average of 1.5 seconds, and then followed by a blank grey screen that 
was displayed for an average of 150 ms (range from 100 ms to 200 ms).  Then, the target 
screen was displayed consisting of a black box (1° x 1°) which appeared to the left or the 
right, 8° from the center of the screen.  Target location was counterbalanced within each 
block so that the target would be presented equally across both locations.  The target 
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screen was shown for 1 second and then was immediately followed by the fixation screen 
for the next trial, except for every tenth trial in which a drift correct was presented. 
Data Cleaning and Extraction 
First, the data were cleaned to exclude invalid trials.  Trials were discarded if the 
latency of the saccade was shorter than 80 ms or longer than 600 ms, consistent with 
previous research (Shelton et al., 2014).  The latency and peak velocity for both the 
prosaccade and antisaccade were analyzed as variables of interest.  Only data from 
accurate saccades were included for these variables.  Accuracy was also examined in the 
antisaccade condition, calculated as the percent of total trials correct.  All participants 
contributed usable data for >80% of trials.  
Data Analysis 
Analyses were conducted using SAS 9.4 (SAS Institute Inc., Cary, NC, USA).  
Data were examined for normality and left skewing of the data was detected for percent 
correct for the antisaccade condition.  The data for this left skewing was transformed by 
lambda of 2.5 using BoxCox procedure (Box & Cox, 1964) to find the optimal power 
transformation.  However, use of the transformed variable analysis had no effect on 
model inferences; thus, analyses on the non-transformed data are reported to facilitate 
interpretation.  In order to examine group differences on performance in each condition, a 
series of linear mixed models were performed, testing the effect of group, block number, 
and the interaction between groups and block number.  Block number was added as a 
predictor to account for order effects.  To address the second research question regarding 
the effect of age, a series of linear mixed models were performed testing the effect of 
group, block number, age, and the interaction between group and age.  Given that the 
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primary models did not support the presence of significant group-by-block interaction 
effects for any of the outcomes, this interaction term was not included in the models 
testing age effects.  The outcomes included latency and peak velocity for the antisaccade 
and prosaccade conditions, and the antisaccade error rates. 
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Chapter 3 
Results 
Group Comparisons on Prosaccade Indices of Voluntary Oculomotor Initiation 
The mixed effects linear model showed a significant main effect for group (F [1, 
60] = 9.01, p = .004; Figure 1), where the FMR1 premutation group displayed longer 
latencies.  Block number (F [1, 60] = 2.02, p = .161) and the interaction between group 
and block number (F [1, 60] = .11, p = .740) did not account for significant variance in 
the model.  The mixed model testing group differences in prosaccade peak velocity 
showed no significant effects for group (F [1, 60] = .02, p = .901), block number (F [1, 
60] = 1.55, p = .218), or group-by-block number interaction (F [1, 60] = .11, p = .744) 
Group Comparisons on Antisaccade Indices of Oculomotor Inhibition 
 The mixed effects linear model showed a significant main effect for group on 
response latency (F [1, 60] = 13.03, p = .001; Figure 2), such that those with the FMR1 
premutation took longer to respond than the control group.  There was no significant 
effect of block number (F [2, 60] = .68, p = .512) or the interaction between group and 
block number (F [2, 60] = 2.65, p = .079) on response latency.  No group (F [1, 60] = .14, 
p = .706), block (F [2, 60] = 2.48, p = .092), or group-by-block (F [2, 60] = .26, p = .771) 
effects were observed for peak velocity.  Finally, the mixed effect model testing the 
percentage of correct responses showed a significant main effect for group (F [1, 60] = 
4.43, p = .040; Figure 3), with those with the FMR1 premutation exhibiting a lower 
percentage of correct responses.  Block number also had a significant effect on percent 
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correct (F [2, 60] = 4.22, p = .019), where accuracy decreased across blocks.  There was 
not a significant interaction between group and block number, indicating that the order 
effect associated with block number was similar across the groups (F [2, 60] = .08, p = 
.926).  
Age Effects on Prosaccade and Antisaccade Performances 
 Age effects were detected for both prosaccade and antisaccade latency variables.  
For the prosaccade model, a significant main effect for age was detected, where longer 
prosaccade latency (averaging across blocks) was associated with older age (F [1, 58] = 
6.67, p = .012).  See Figure 4.  The interaction between group and age was not significant 
(F [1, 58] = 1.20, p = .278), indicating that the association between age and prosaccade 
latency was similar across the groups.  Block did not account for significant variance in 
the model (F [1, 58] = 1.92, p = .171).  For the antisaccade latency outcome, the main 
effect of age was not significant (F [1, 58] = 2.75, p = .103) but a significant group-by-
age interaction was detected where older age was associated with longer latency 
(examining averages across blocks) in the FMR1 premutation group but not in controls (F 
[1, 58] = 6.43, p = .014), see Figure 5.  The effect of block was not significant (F [2, 58]= 
0.98 p = .383).  No main effects or interaction effects for age were observed for any of 
the other prosaccade or antisaccade outcomes (ps> .101).
  14
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Prosaccade latency across blocks and groups 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Antisaccade latency across blocks and groups 
 
 
Note. FXpm = FMR1 Premutation 
Note. FXpm = FMR1 Premutation 
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Figure 3.3 Antisaccade percent correct across 
blocks and groups 
 
 
 
 
 
 
 
 
 
Figure 3.4 Association between age and prosaccade latency 
(average across blocks) 
Note. FXpm = FMR1 Premutation 
 
Note. FXpm = FMR1 Premutation 
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Figure 3.5 Association between age and antisaccade latency (average 
across blocks) across the groups 
 
Note. FXpm = FMR1 Premutation 
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Chapter 4 
Discussion 
The primary aim of this study was to further examine executive functioning 
deficits in women with the FMR1 premutation.  We used the antisaccade task, a measure 
sensitive to the timing of executive responses, which therefore may have increased 
sensitivity to subtle executive problems.  We found that women with the FMR1 
premutation had significantly increased response latency and increased errors in the 
antisaccade condition suggesting inhibition deficits.  Increased latency in the prosaccade 
condition was also detected, implying deficits in oculomotor abilities, specifically in 
motor initiation.  Our secondary aim was to examine effects of aging within the FMR1 
premutation.  Longer antisaccade latency was associated with older age in the FMR1 
premutation group, suggesting premature age-related decline in oculomotor inhibition in 
this population.  These findings contribute to previous research supporting executive 
functioning deficits within this population as well as provide information with regards to 
identification of the age-related profile of this population that may inform prevention 
effort. 
Group Differences on Antisaccade Latency & Percent Correct 
Our findings suggest oculomotor inhibition difficulties in women with the FMR1 
premutation, as evidenced by poorer timing and accuracy on the antisaccade task relative 
to controls.  Our findings notably support evidence of a previous study conducted by 
Shelton et al. (2014) that also detected increased antisaccade errors in women with the 
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FMR1 premutation.  Inhibitory control deficits have also been observed in women with 
the FMR1 premutation using other behavioral measures, such as the Hayling Sentence 
Completion test which requires verbal inhibition of a prepotent response (Kraan et al., 
2014; Shelton et al., 2014).  Thus our findings build on a growing body of evidence that 
supports inhibition deficits as an aspect of the FMR1 premutation phenotype. 
Age Effects Suggest Premature Age-Related Decline in the FMR1 Premutation 
 We observed an association between older age and slower antisaccade latencies 
that was specific to the FMR1 premutation group.  This finding corroborates the results of 
our other recent report demonstrating age-related decline in verbal inhibition skills in 
women with the FMR1 premutation (Klusek et al., 2020).  In this study including a large 
sample of over 100 women with the FMR1 premutation, we detected an association 
between older age and prolonged latency to inhibit an automatic verbal response during 
the Hayling Sentence Completion test.  The current study builds on our prior findings 
through the inclusion of a control sample that allows us to confirm the specificity of the 
age effects to the FMR1 premutation group.  Curiously, age effects were specific to the 
latency variable and were not observed in error rate on the antisaccade task as well.  This 
finding supports the idea that measures that require rapid, time responses may be a more 
sensitive measure to executive deficits in the FMR1 premutation (Shelton et al., 2014).  
Overall, the results of this study suggest that executive functioning deficits in women 
with the FMR1 premutation become more pronounced across middle adulthood, which 
may be important for the timing or prevention efforts and the development of 
interventions to support this group as they age. 
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Prosaccade Findings 
 In the prosaccade portion of this task, we found similar results to the antisaccade, 
with prolonged latencies for women with the FMR1 premutation.  Prosaccade 
performance reflects voluntary motor control and cognitive control (Yang et al., 2011; 
Munoz et al., 1998).  With increased time to initiate this motor movement, this result 
infers that processing time is delayed in women with the FMR1 premutation.  Age effects 
were also observed for prosaccade latency, where older age was associated with longer 
latency.  However, unlike the antisaccade age effects which were specific to the FMR1 
premutation group, both controls and women with the FMR1 premutation showed longer 
prosaccade latency with age, suggesting that this is a normal pattern in healthy aging.  
These results suggest that inhibition skills may be more accurate than motor initiation in 
predicting the future progression of the disorder.  This is somewhat surprising given that 
FXTAS, the neurodegenerative disease associated with the FMR1 premutation, has a 
large motor component.                     
Strengths and Future Aims 
Strengths of the present study include adding to prior studies with a larger sample 
size of participants of both women with the FMR1 premutation as well as the control 
group.  Previous studies are limited, with only one examining women with the FMR1 
premutation in which a sample size of 14 was included (Shelton et al., 2014).  Of 
particular importance, the antisaccade task is backed by a significant amount of research 
to quantify cognitive deficits within various populations, especially those with 
neurodegenerative disorders.  Protocol for this task was standardized based on 
Antoniades et al. (2013) for accurate comparison in future studies.   
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A future direction would be to examine performance on this task between women 
with the FMR1 premutation without FXTAS and those women with FXTAS to determine 
any subtle differences.  Similarly, longitudinal studies may be important to determine the 
onset and progression of FXTAS.  Due to a paucity of evidence in women with the FMR1 
premutation, it is unknown whether oculomotor abnormalities are prevalent in FXTAS, 
or whether they precede the onset of other FXTAS motor signs.  It is possible that eye 
movements can provide valuable markers of disease progression and severity in 
neurodegenerative disorders (Anderson & MacAskill, 2013).  
Conclusions  
Compared to controls, women with the FMR1 premutation exhibited prolonged 
latencies in the antisaccade task with and without age factors included, illustrating the 
subtle inhibition deficits within this population.  Similarly, women with the FMR1 
premutation had fewer successful trials on the antisaccade portion of the task again 
showing inhibition deficits.  Finally, women with the FMR1 premutation displayed 
prolonged latencies on the prosaccade portion of this task, implying a possible motor 
component to this disorder.  Thus, this is a benchmark study in examining executive 
dysfunction within women with the FMR1 premutation.  These deficits may contribute to 
a decreased quality of life in women with the FMR1 premutation and may necessitate 
clinical intervention in the future to aid in prevention of the progressive nature of this 
disorder. 
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